Makowska A, Kontny U, van Helden J, Hildebrandt B, Schuler H, Weiskirchen R
Cancer Med. 2025; 14(3):e70422.
PMID: 39905741
PMC: 11794828.
DOI: 10.1002/cam4.70422.
Zhu Q, Duan X, Hu H, You R, Xia T, Yu T
J Transl Med. 2024; 22(1):1111.
PMID: 39695702
PMC: 11653747.
DOI: 10.1186/s12967-024-05822-3.
Chen W, Chen W, Chen S, Jiang L, Shu G, Yin Y
Cancer Biol Ther. 2024; 25(1):2382531.
PMID: 39206791
PMC: 11364074.
DOI: 10.1080/15384047.2024.2382531.
Chen J, Pang Y, Liao X, Zhou Y, Luo Q, Wu H
Eur J Nucl Med Mol Imaging. 2024; 52(1):247-259.
PMID: 39145784
DOI: 10.1007/s00259-024-06874-9.
Wu M, Hau P, Li L, Tsang C, Yang Y, Taghbalout A
Nat Commun. 2024; 15(1):3729.
PMID: 38702330
PMC: 11068728.
DOI: 10.1038/s41467-024-48031-8.
HeLa cells cross-contaminated nasopharyngeal carcinoma cell lines: Still a common problem.
Makowska A, Kontny U, Weiskirchen R
Br J Cancer. 2024; 130(12):1885-1886.
PMID: 38664578
PMC: 11182765.
DOI: 10.1038/s41416-024-02675-x.
Synthesis and Evaluation of [Cu]Cu-NOTA-HFn for PET Imaging of Transferrin Receptor 1 Expression in Nasopharyngeal Carcinoma.
Shen Y, Zhou R, Bi L, Huang G, Yang M, Li Z
ACS Omega. 2024; 9(15):17423-17431.
PMID: 38645324
PMC: 11024937.
DOI: 10.1021/acsomega.4c00187.
Nasopharyngeal Carcinoma Cell Lines: Reliable Alternatives to Primary Nasopharyngeal Cells?.
Makowska A, Weiskirchen R
Cells. 2024; 13(7.
PMID: 38606998
PMC: 11011377.
DOI: 10.3390/cells13070559.
Activation of Epstein-Barr Virus' Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide.
Hartman-Houstman H, Swenson S, Minea R, Sinha U, Chiang M, Chen T
Cancers (Basel). 2024; 16(5).
PMID: 38473298
PMC: 10931041.
DOI: 10.3390/cancers16050936.
TPGS-b-PBAE Copolymer-Based Polyplex Nanoparticles for Gene Delivery and Transfection In Vivo and In Vitro.
Ding J, Zhang H, Dai T, Gao X, Yin Z, Wang Q
Pharmaceutics. 2024; 16(2).
PMID: 38399267
PMC: 10891721.
DOI: 10.3390/pharmaceutics16020213.
Establishment and Characterization of an Epstein-Barr Virus-positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal Carcinoma.
Chai A, Yee S, Lee H, Aziz N, Yee P, Marzuki M
Cancer Res Commun. 2024; 4(3):645-659.
PMID: 38358347
PMC: 10911800.
DOI: 10.1158/2767-9764.CRC-23-0341.
BGLF4 kinase regulates the formation of the EBV cytoplasmic assembly compartment and the recruitment of cellular IQGAP1 for virion release.
Dai Y, Yeh S, Cheng Y, Huang W, Liou G, Yang T
J Virol. 2024; 98(2):e0189923.
PMID: 38294245
PMC: 10878254.
DOI: 10.1128/jvi.01899-23.
Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models.
Lam R, Hui C, Wong C, Lo K, Tsang A, Hui E
Invest New Drugs. 2023; 41(5):699-709.
PMID: 37572231
DOI: 10.1007/s10637-023-01384-1.
Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein-Barr Virus LMP1 Protein.
Khenchouche A, Salem-Bekhit M, Mansour A, Alomary M, Wang X, Alzahrani H
Microorganisms. 2023; 11(7).
PMID: 37512884
PMC: 10383785.
DOI: 10.3390/microorganisms11071712.
Super Enhancer Driven Hyaluronan Synthase 3 Promotes Malignant Progression of Nasopharyngeal Carcinoma.
Chen Q, Peng Q, Cai J, Liu Y, Lu X, Xiong W
J Cancer. 2023; 14(10):1751-1762.
PMID: 37476195
PMC: 10355197.
DOI: 10.7150/jca.83954.
Conditional Cell Reprogramming and Air-Liquid Interface Modeling Life Cycle of Oncogenic Viruses (HPV and EBV) in Epithelial Cells and Virus-Associated Human Carcinomas.
Rani A, Nurmemet D, Liffick J, Khan A, Mitchell D, Li J
Viruses. 2023; 15(6).
PMID: 37376685
PMC: 10302659.
DOI: 10.3390/v15061388.
Photodynamic Therapy Can Modulate the Nasopharyngeal Carcinoma Microenvironment Infected with the Epstein-Barr Virus: A Systematic Review and Meta-Analysis.
Fornel D, Ferrisse T, de Oliveira A, Fontana C
Biomedicines. 2023; 11(5).
PMID: 37239013
PMC: 10216108.
DOI: 10.3390/biomedicines11051344.
Mitochondrial non-coding RNA in nasopharyngeal carcinoma: Clinical diagnosis and functional analysis.
Wang F, Li X, Li C
Front Genet. 2023; 14:1162332.
PMID: 37035732
PMC: 10076541.
DOI: 10.3389/fgene.2023.1162332.
miR-26b Targets CEP135 Gene to Regulate Nasopharyngeal Carcinoma Proliferation and Migration by NF-κB Pathway.
Yang G, Zhou J, Guo Z, Fan L, Chen B, Zhang D
Mol Biotechnol. 2023; 65(11):1857-1868.
PMID: 36820950
PMC: 10518290.
DOI: 10.1007/s12033-023-00691-5.
GMP development and preclinical validation of CAR-T cells targeting a lytic EBV antigen for therapy of EBV-associated malignancies.
Zhang X, Wang T, Zhu X, Lu Y, Li M, Huang Z
Front Immunol. 2023; 14:1103695.
PMID: 36817460
PMC: 9932894.
DOI: 10.3389/fimmu.2023.1103695.